Press release

DSM brings innovative therapeutic concepts to CPhI 2017

Kaiseraugst, CH, 29 Aug 2017 12:00 CEST

Royal DSM, a global science-based company active in health, nutrition and materials, is to showcase new therapeutic concepts featuring active pharmaceutical ingredients (APIs), particularly vitamins and lipids for pharmaceutical applications, at CPhI. Covering diverse fields such as hypertension, diabetes, irritable bowel syndrome, breast cancer, prostate cancer and multiple sclerosis, the concepts demonstrate how DSM can use its high quality products to innovate and support customers in getting to market faster.

This year, the stand will contain three ‘expert stations’, where visitors can meet with DSM experts in various fields to receive support specific to the needs of their own pharmaceutical business. At the first station, individuals can learn about DSM’s innovation projects in vitamins and lipids, including new therapeutic applications. Here, they can get support on developing a concept for launch, leveraging DSM’s pioneering expertise.

The second station will focus on DSM’s unparalleled regulatory support for pharmaceutical projects and strong track record with regulatory authorities worldwide. Attendees will learn how their new products can get to market faster when working with DSM – currently the only company in the world to hold CEP certificates for all vitamins. DSM is also continuously expanding its global reach, now offering Drug Master Files (DMFs) for the US.

Last but not least, there will also be an expert station focused on sustainable sourcing. Visitors working in purchasing and sourcing will find out how they can benefit from DSM’s proven success in quality assurance, sustainable practices and reliable supply. With GMP qualified production sites, DSM is committed to making substantial future investments in quality and sustainability across its global production network, in line with its Quality for Life™ principles.

From its proud heritage as the former Vitamins and Fine Chemicals Division of Roche Vitamins, DSM has continued to invest in pioneering new science and evolve its capabilities in vitamin and lipid manufacturing for pharmaceutical applications. DSM will share its booth with colleagues from DSM Sinochem Pharmaceuticals, who will highlight sustainable solutions for APIs and Drug Products.

For more information

Nelleke Barning

Global Communications and External Affairs Director
+41 618 158 502